migramax powder for oral solution
sanofi-synthelabo ireland ltd - acetylsalicylate lysine metoclopramide hydrochloride - powder for oral solution
skainar caps capsule
eisai - acetylsalicylate, diphenylpyraline, lysozyme - capsule
migpriv 900 mg - 10 mg or. sol. (pwdr.) sachet
cooperation pharmaceutique francaise - metoclopramide hydrochloride monohydrate 10,54 mg - eq. metoclopramide hydrochloride 10 mg; acetylsalicylate lysine 1620 mg - eq. acetylsalicylic acid 900 mg - powder for oral solution - acetylsalicylic acid, combinations excl. psycholeptics
aspegic powder (otc)
acetylsalicylate d-lysine 500mg
aspergic injection (pom)
dl-lysine acetylsalicylate 900mg
skyrizi solution for injection in pre-filled syringe 150mgml
abbvie sdn bhd - risankizumab -
skyrizi solution for injection in pre-filled pen 150mgml
abbvie sdn bhd - risankizumab -
diltiazem sandoz diltiazem hydrochloride 60mg tablet bottle
sandoz pty ltd - diltiazem hydrochloride -
diltiazem sandoz diltiazem hydrochloride 60mg tablet blister pack
sandoz pty ltd - diltiazem hydrochloride -
cardizem diltiazem hydrochloride 60mg tablet bottle
sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; quinoline yellow; microcrystalline cellulose; methyl hydroxybenzoate; hypromellose; sunset yellow fcf; colloidal anhydrous silica; hyprolose; macrogol 3350; macrogol 400 - patients with moderate to severe angina pectoris due to atherosclerotic coronary artery disease or coronary artery spasm (vasospastic angina).